UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT


Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported)  February 28, 2014


MOKITA, INC.

(Exact name of registrant as specified in its charter)


Nevada

333-167275

46-0525378

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)


7695 SW 104th Street, Suite 210, Miami, Florida

33156

(Address of principal executive offices)

(Zip Code)


Registrant’s telephone number, including area code  (305) 663-7140


N/A

(Former name or former address, if changed since last report.)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


      .Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

      .Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

      .Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

      .Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





Item 8.01

Other Items


On February 28, 2014, we received written consent from our company’s board of directors and the holders of 51.47% of our company’s voting securities to change the name of our company to “MediJane Holdings Inc.”


Pursuant to Section 78.320 of the Nevada Revised Statues, any action required or permitted to be taken at a meeting of the stockholders may be taken without a meeting if a written consent to such action is signed by stockholders holding at least a majority of the voting power and on February 28, 2014, we received written consent from the holders of 51.47% of our company’s voting securities, for a name change to “MediJane Holdings Inc.”.


The amendment is currently under review with the Financial Industry Regulatory Authority (“FINRA”).  We will announce the completion of FINRA review and the effectiveness of these changes on the market by filing a Current Report on Form 8-K.






SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


MOKITA, INC.

 

/s/ Ronald Lusk

Ronald Lusk

President and Director

Date:  March 4, 2014




2